Trial Profile
Efficacy of intravitreal injection of ranibizumab in patients with retinopathy of prematurity : A retrospective case series study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 14 Oct 2016 New trial record